Cross-sectional study of host immune responses stimulated by bifidobacteria and lactobacilli in relation to intestinal microbiota and lifestyle
- Conditions
- one
- Registration Number
- JPRN-UMIN000052004
- Lead Sponsor
- MORINAGA MILK INDUSTRY CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Not provided
1)Subjects with serious disorders on malignant tumors, respiratory disease, hepatic, kidney, cardiac, lung, digestive organs, blood, endocrine system and metabolic system, or related severe past medical histories 2)Subjects with medication allergy, food allergy, or serious history of these 3)Subjects who are pregnant, under lactation or expecting to be pregnant during this study 4)Subjects with suffering from autoimmune diseases 5)Subjects who plan to use drugs that may affect immune response and intestinal flora (antiallergic agents, anti-inflammatory agents, antibiotics, drugs for digestive system treatment, diabetes drugs) from the time consent is obtained to the end of the study. 6)Subjects who plan to be vaccinated against influenza, COVID-19, or other infectious diseases from the time consent is obtained to the end of the study. 7)Any candidates considered to be inappropriate for this study by the principal investigator based on their background, physical examination, etc.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of immunity parameters, Intestinal flora, Survey of background information on the subject
- Secondary Outcome Measures
Name Time Method